The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: A PET, histological and biochemical study

被引:82
作者
Blesa, J. [1 ,2 ,3 ]
Pifl, C. [4 ,5 ]
Sanchez-Gonzalez, M. A. [6 ,8 ]
Juri, C. [1 ,2 ,7 ]
Garcia-Cabezas, M. A. [6 ,8 ]
Adanez, R. [1 ,2 ,3 ]
Iglesias, E. [1 ,2 ,3 ]
Collantes, M. [9 ]
Penuelas, I. [9 ]
Sanchez-Hernandez, J. J. [10 ]
Rodriguez-Oroz, M. C. [1 ,2 ,3 ]
Avendano, C. [6 ,8 ]
Hornykiewicz, O. [4 ,5 ]
Cavada, C. [6 ,8 ]
Obeso, J. A. [1 ,2 ,3 ]
机构
[1] Univ Navarra Clin, CIMA, Div Neurosci, Movement Disorders Grp, Pamplona, Spain
[2] Univ Navarra Clin, Dept Neurol & Neurosurg, Pamplona, Spain
[3] Minist Ciencia & Innovac, Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain
[4] Med Univ Vienna, Ctr Brain Res, Vienna, Austria
[5] Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain
[6] Inst Invest Sanitaria IdiPAZ, Madrid, Spain
[7] Pontificia Univ Catolica Chile, Dept Neurol, Santiago, Chile
[8] Ctr Appl Med Res CIMA, Small Anim Imaging Res Unit, Pamplona, Spain
[9] Univ Navarra Clin, Dept Nucl Med, Pamplona, Spain
[10] Univ Autonoma Madrid, Fac Med, Dept Med Prevent & Salud Publ, Madrid, Spain
关键词
MPTP monkey; Parkinson's disease; PET; AAAD; Compensatory mechanisms; VESICULAR MONOAMINE TRANSPORTER; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; COMPENSATORY MECHANISMS; BASAL GANGLIA; TREATED MONKEYS; RHESUS-MONKEY; RATING-SCALE; ANIMAL-MODEL; DOPAMINE;
D O I
10.1016/j.nbd.2012.05.018
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Parkinson's disease (PD) is diagnosed when striatal dopamine (DA) loss exceeds a certain threshold and the cardinal motor features become apparent. The presymptomatic compensatory mechanisms underlying the lack of motor manifestations despite progressive striatal depletion are not well understood. Most animal models of PD involve the induction of a severe dopaminergic deficit in an acute manner, which departs from the typical, chronic evolution of PD in humans. We have used 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP) administered to monkeys via a slow intoxication protocol to produce a more gradual development of nigral lesion. Twelve control and 38 MPTP-intoxicated monkeys were divided into four groups. The latter included monkeys who were always asymptomatic, monkeys who recovered after showing mild parkinsonian signs, and monkeys with stable, moderate and severe parkinsonism. We found a close correlation between cell loss in the substantia nigra pars compacta (SNc) and striatal dopaminergic depletion and the four motor states. There was an overall negative correlation between the degree of parkinsonism (Kurlan scale) and in vivo PET (F-18-DOPA K-i and C-11-DTBZ binding potential), as well as with TH-immunoreactive cell counts in SNc, striatal dopaminergic markers (TH, DAT and VMAT2) and striatal DA concentration. This intoxication protocol permits to establish a critical threshold of SNc cell loss and dopaminergic innervation distinguishing between the asymptomatic and symptomatic parkinsonian stages. Compensatory changes in nigrostriatal dopaminergic activity occurred in the recovered and parkinsonian monkeys when DA depletion was at least 88% of control, and accordingly may be considered too late to explain compensatory mechanisms in the early asymptomatic period. Our findings suggest the need for further exploration of the role of non-striatal mechanisms in PD prior to the development of motor features. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:79 / 91
页数:13
相关论文
共 59 条
[1]
'Passive stabilization' of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6-OHDA-lesioned rat [J].
Bergstrom, BP ;
Garris, PA .
JOURNAL OF NEUROCHEMISTRY, 2003, 87 (05) :1224-1236
[2]
BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5
[3]
Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms [J].
Bézard, E ;
Boraud, T ;
Bioulac, B ;
Gross, CE .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1999, 11 (06) :2167-2170
[4]
Presymptomatic compensation in Parkinson's disease is not dopamine-mediated [J].
Bezard, E ;
Gross, CE ;
Brotchie, JM .
TRENDS IN NEUROSCIENCES, 2003, 26 (04) :215-221
[5]
Compensatory effects of glutamatergic inputs to the substantia nigra pars compacta in experimental Parkinsonism [J].
Bezard, E ;
Boraud, T ;
Bioulac, B ;
Gross, CE .
NEUROSCIENCE, 1997, 81 (02) :399-404
[6]
Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease [J].
Bezard, E ;
Dovero, S ;
Prunier, C ;
Ravenscroft, P ;
Chalon, S ;
Guilloteau, D ;
Crossman, AR ;
Bioulac, B ;
Brotchie, JM ;
Gross, CE .
JOURNAL OF NEUROSCIENCE, 2001, 21 (17) :6853-6861
[7]
Bezard Erwan, 2001, FASEB Journal, V15, P1092
[8]
The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future [J].
Bjorklund, Anders ;
Cenci, M. Angela .
RECENT ADVANCES IN PARKINSONS DISEASE: TRANSLATIONAL AND CLINICAL RESEARCH, 2010, 184 :133-157
[9]
Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion: a possible compensatory mechanism in Parkinson's disease [J].
Blesa, Javier ;
Juri, Carlos ;
Garcia-Cabezas, Miguel A. ;
Adanez, Rebeca ;
Sanchez-Gonzalez, Miguel A. ;
Cavada, Carmen ;
Obeso, Jose A. .
FRONTIERS IN SYSTEMS NEUROSCIENCE, 2011, 5
[10]
Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An 18F-DOPA and 11C-DTBZ PET study [J].
Blesa, Javier ;
Juri, Carlos ;
Collantes, Maria ;
Penuelas, Ivan ;
Prieto, Elena ;
Iglesias, Elena ;
Marti-Climent, Josep ;
Arbizu, Javier ;
Zubieta, Jose L. ;
Cruz Rodriguez-Oroz, Mari ;
Garcia-Garcia, David ;
Richter, Jose A. ;
Cavada, Carmen ;
Obeso, Jose A. .
NEUROBIOLOGY OF DISEASE, 2010, 38 (03) :456-463